BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8530331)

  • 1. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS; Friedman JH; Ott BR
    J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH
    J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
    Wolk SI; Douglas CJ
    J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of clozapine in Brazilian patients with Parkinson's disease.
    Gomide L; Kummer A; Cardoso F; Teixeira AL
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):611-4. PubMed ID: 18949249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine therapy for Parkinson's disease and other movement disorders.
    Pfeiffer C; Wagner ML
    Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosis.
    Klein C; Prokhorov T; Miniovich A; Dobronevsky E; Rabey JM
    Clin Neuropharmacol; 2006; 29(4):215-9. PubMed ID: 16855423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
    Meco G; Alessandri A; Giustini P; Bonifati V
    Mov Disord; 1997 Jul; 12(4):610-2. PubMed ID: 9251085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.